| Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ... Cancer cell 34 (6), 996-1011. e8, 2018 | 272 | 2018 |
| Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer SE Jalava, A Urbanucci, L Latonen, KK Waltering, B Sahu, OA Jänne, ... Oncogene 31 (41), 4460-4471, 2012 | 265 | 2012 |
| Androgen receptor (AR) aberrations in castration-resistant prostate cancer KK Waltering, A Urbanucci, T Visakorpi Molecular and cellular endocrinology 360 (1-2), 38-43, 2012 | 247 | 2012 |
| Androgen regulation of micro‐RNAs in prostate cancer KK Waltering, KP Porkka, SE Jalava, A Urbanucci, PJ Kohonen, ... The Prostate 71 (6), 604-614, 2011 | 199 | 2011 |
| Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer A Urbanucci, B Sahu, J Seppälä, A Larjo, LM Latonen, KK Waltering, ... Oncogene 31 (17), 2153-2163, 2012 | 191 | 2012 |
| Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ... Cell reports 19 (10), 2045-2059, 2017 | 145 | 2017 |
| c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks SJ Barfeld, A Urbanucci, HM Itkonen, L Fazli, JL Hicks, B Thiede, ... EBioMedicine 18, 83-93, 2017 | 126 | 2017 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Nature communications 12 (1), 5307, 2021 | 94 | 2021 |
| Androgen-regulated metabolism and biosynthesis in prostate cancer SJ Barfeld, HM Itkonen, A Urbanucci, IG Mills Endocrine-related cancer 21 (4), T57-T66, 2014 | 93 | 2014 |
| Androgen regulation of the androgen receptor coregulators A Urbanucci, KK Waltering, HE Suikki, MA Helenius, T Visakorpi BMC cancer 8, 1-10, 2008 | 85 | 2008 |
| Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer SJ Barfeld, L Fazli, M Persson, L Marjavaara, A Urbanucci, ... Oncotarget 6 (14), 12587, 2015 | 81 | 2015 |
| High OGT activity is essential for MYC-driven proliferation of prostate cancer cells HM Itkonen, A Urbanucci, SES Martin, A Khan, A Mathelier, B Thiede, ... Theranostics 9 (8), 2183, 2019 | 80 | 2019 |
| Lipid degradation promotes prostate cancer cell survival HM Itkonen, M Brown, A Urbanucci, G Tredwell, CH Lau, S Barfeld, C Hart, ... Oncotarget 8 (24), 38264, 2017 | 74 | 2017 |
| Drivers of AR indifferent anti-androgen resistance in prostate cancer cells F Handle, S Prekovic, C Helsen, T Van den Broeck, E Smeets, L Moris, ... Scientific reports 9 (1), 13786, 2019 | 66 | 2019 |
| Potential internalisation of caliciviruses in lettuce A Urbanucci, M Myrmel, I Berg, CH Von Bonsdorff, L Maunula International journal of food microbiology 135 (2), 175-178, 2009 | 64 | 2009 |
| Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression S Cao, JR Wang, S Ji, P Yang, Y Dai, S Guo, MD Montierth, JP Shen, ... Nature biotechnology 40 (11), 1624-1633, 2022 | 60 | 2022 |
| The expression of AURKA is androgen regulated in castration-resistant prostate cancer K Kivinummi, A Urbanucci, K Leinonen, TLJ Tammela, M Annala, ... Scientific reports 7 (1), 17978, 2017 | 56 | 2017 |
| CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions E Fiorito, Y Sharma, S Gilfillan, S Wang, SK Singh, SV Satheesh, ... Nucleic acids research 44 (22), 10588-10602, 2016 | 50 | 2016 |
| Inhibition of O-GlcNAc transferase renders prostate cancer cells dependent on CDK9 HM Itkonen, N Poulose, RE Steele, SES Martin, ZG Levine, DY Duveau, ... Molecular Cancer Research 18 (10), 1512-1521, 2020 | 46 | 2020 |
| Cell cycle-coupled expansion of AR activity promotes cancer progression C McNair, A Urbanucci, CES Comstock, MA Augello, JF Goodwin, ... Oncogene 36 (12), 1655-1668, 2017 | 43 | 2017 |
